Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.

Shanghai Lingtai Biomedical Technology Co., Ltd., established on 2019-09-20, Business scope includes general items:engaged in biotechnology,Medical Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development in the field,Technical Services,technical consulting,technology transfer;Engaged in the import and export of goods and technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex chemicals of life by reconfiguring natural substances into best-in-class medicines. REVOLUTION Medicines builds upon the vision of the company’s founder, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute, who invented a transformative method for synthesizing original compounds that are pharmaceutically optimized analogues of complex natural products. REVOLUTION Medicines has entered into an exclusive license agreement with the University of Illinois to practice and expand this technology. REVOLUTION Medicines’ approach is a rapid, standardized and powerful process for assembling simple “chemical building blocks” into refined natural product-like structures. These optimized compounds have significant potential as best-in-class drug candidates.

Part of Regor Therapeutics Group, Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd. is a company headquartered in Shanghai, China, that develops pharmaceutical products. It was founded in 2018.

Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of innovative small molecule targeted protein degraders (TPDs) for the treatment of a wide range of diseases with an initial focus on cancer. Members of our founding and scientific teams previously developed the first FDA approved modulators of Cereblon, the most widely validated E3 ligase involved in protein degradation, and have applied their expertise in Cereblon binding to build our proprietary PRODEGY platform. Our platform leverages an extensive patent protected and rationally designed library of Cereblon binders that we believe provides us with a differentiated starting point for drug design of molecular glues, bifunctional degraders and hybrid degraders.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Beijing Huanuo Ogilvy Medical Laboratory Co., Ltd., established on 2015-10-10, The scope of business includes clinical laboratory services;Medicine and Research and Experimental Development.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Wuhan Aidikang Medical Laboratory Co., Ltd., established on 2009-11-24, Business scope includes self-management and agency of various commodities and technology import and export business(Excluding commodities and technologies that are restricted or prohibited from import and export by the state).Business Consulting;medical instruments(one type)Sales;computer software development,Sales,Technical Services;Medical Laboratory(clinical body fluid,blood specialty,clinical microbiology major,clinical chemistry laboratory,clinical immunization,Serology major,Clinical Cytomolecular Genetics Major),Pathology;road freight transport.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Kangxu Gene Technology (Beijing) Co., Ltd., established on 2011-06-30, Business scope includes technology development,Technical Services,technical consulting,technology transfer;computer technology training;Agent import and export,Import and export,Technology Import and Export;Organize cultural and artistic exchange activities;translation service;Economic and Trade Consulting;Family labor service;Undertake exhibition and display activities;Conference Services.(Except for projects without administrative permission)(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)